NPI: 1215287941 · MOUNT LAUREL, NJ 08054 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/10/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 09/10/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,546 | $873K |
| 2019 | 5,358 | $177K |
| 2020 | 8,886 | $355K |
| 2021 | 7,348 | $207K |
| 2022 | 14,105 | $320K |
| 2023 | 5,242 | $280K |
| 2024 | 961 | $68K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 20,163 | 1,471 | $1.79M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 14,641 | 853 | $321K |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,713 | 307 | $34K |
| J1756 | Injection, iron sucrose, 1 mg | 2,979 | 515 | $32K |
| A4657 | Syringe, with or without needle, each | 3,498 | 1,104 | $24K |
| 83550 | 581 | 516 | $20K | |
| 83540 | 615 | 528 | $20K | |
| 83970 | 370 | 220 | $12K | |
| 85048 | 570 | 476 | $9K | |
| 85041 | 559 | 475 | $8K | |
| 82728 | 260 | 207 | $7K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 386 | 116 | $101.11 |
| G0008 | Administration of influenza virus vaccine | 44 | 32 | $41.32 |
| 82108 | 12 | 12 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 43 | 26 | $0.00 |
| 90674 | 12 | 12 | $0.00 |